Company Overview

Update
Founded:
1993
Founders:
Thomas Neff
Headquarters:
San Francisco, CA
Funding:
$106M
Categories:
Biotechnology
Description:
FibroGen, a research-based biotech firm, uses its expertise CTGF and HIF biology to discover, develop, and commercialize novel therapeutics.

Detailed Description

Update

FibroGen is a research-based biotechnology company using its expertise in connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology to discover, develop, and commercialize novel therapeutics for serious unmet medical needs.

Current Team (11)

Update

Past Team (3)

Update

Board Members and Advisors (9)

Update

Investors (13)

Update

Offices/Locations (1)

Update
  • Office

    409 Illinois St.

    San Francisco, CA 94158

    USA

Images (1)

Update
  • F83c5aa8bb571c5303e01845c05f210f